- Home
- BMRA vs MIRA Comparison
BMRA vs MIRA Comparison
Compare BMRA & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRA
- MIRA
- Stock Information
- Founded
- BMRA 1971
- MIRA 2020
- Country
- BMRA United States
- MIRA United States
- Employees
- BMRA N/A
- MIRA N/A
- Industry
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- MIRA Biotechnology: Pharmaceutical Preparations
- Sector
- BMRA Health Care
- MIRA Health Care
- Exchange
- BMRA Nasdaq
- MIRA Nasdaq
- Market Cap
- BMRA 7.4M
- MIRA 17.1M
- IPO Year
- BMRA N/A
- MIRA 2023
- Fundamental
- Price
- BMRA $0.33
- MIRA $1.05
- Analyst Decision
- BMRA
- MIRA Strong Buy
- Analyst Count
- BMRA 0
- MIRA 2
- Target Price
- BMRA N/A
- MIRA $14.00
- AVG Volume (30 Days)
- BMRA 68.2K
- MIRA 538.5K
- Earning Date
- BMRA 10-15-2024
- MIRA 11-11-2024
- Dividend Yield
- BMRA N/A
- MIRA N/A
- EPS Growth
- BMRA N/A
- MIRA N/A
- EPS
- BMRA N/A
- MIRA N/A
- Revenue
- BMRA $5,509,000.00
- MIRA N/A
- Revenue This Year
- BMRA N/A
- MIRA N/A
- Revenue Next Year
- BMRA N/A
- MIRA N/A
- P/E Ratio
- BMRA N/A
- MIRA N/A
- Revenue Growth
- BMRA 1.74
- MIRA N/A
- 52 Week Low
- BMRA $0.24
- MIRA $0.51
- 52 Week High
- BMRA $2.13
- MIRA $6.40
- Technical
- Relative Strength Index (RSI)
- BMRA 47.85
- MIRA 38.49
- Support Level
- BMRA $0.28
- MIRA $1.05
- Resistance Level
- BMRA $0.35
- MIRA $1.12
- Average True Range (ATR)
- BMRA 0.04
- MIRA 0.07
- MACD
- BMRA 0.00
- MIRA 0.02
- Stochastic Oscillator
- BMRA 41.67
- MIRA 12.00
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Europe market.
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.